Vimarsana
Biggest News Aggregation in the World

Page 2 - Barnaby Balmforth News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Barnaby Balmforth. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Barnaby Balmforth Today - Breaking & Trending Today

Biofidelity announces the commercial launch of ASPYRE-Lung in the US - Vimarsana News

Biofidelity announces the commercial launch of ASPYRE-Lung in the US

/PRNewswire/ -- Biofidelity, a revolutionary genomic technology company dedicated to bringing the benefits of precision medicine to patients around the world,...

Matt Franklin, MBA, appointed as Biofidelity Non-Executive Director - Vimarsana News

Matt Franklin, MBA, appointed as Biofidelity Non-Executive Director

/PRNewswire/ -- Biofidelity, a revolutionary genomic technology company, has expanded its Board of Directors to include Matt Franklin, MBA, who will join as a...

New data demonstrates novel genomic technology provides ultra-sensitive detection of gene fusions from RNA - Vimarsana News

New data demonstrates novel genomic technology provides ultra-sensitive detection of gene fusions from RNA

/PRNewswire/ -- Biofidelity, a revolutionary genomic technology company, has developed a low-cost, simple and rapid assay for single-molecule detection of...

Biofidelity granted key patents in US, Europe, and China - Vimarsana News

Biofidelity granted key patents in US, Europe, and China

/PRNewswire/ -- Biofidelity, a revolutionary genomic technology company dedicated to unleashing the potential of genomics to transform human health and the...

Biofidelity To Launch New Cancer Diagnostic; Recent Funding Means Bigger RTP Presence | North Carolina Biotechnology Center - Vimarsana News

Biofidelity To Launch New Cancer Diagnostic; Recent Funding Means Bigger RTP Presence | North Carolina Biotechnology Center

$23 million in new funding will help beef up British cancer diagnostics startup Biofidelity’s U.S. headquarters activity in RTP as it prepares to launch its first commercial product.